MetLife, Inc.
MET · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $55 | $54 | $55 | $57 |
| - Cash | $20 | $22 | $21 | $20 |
| + Debt | $20 | $16 | $15 | $19 |
| Enterprise Value | $55 | $48 | $49 | $56 |
| Revenue | $17 | $17 | $18 | $18 |
| % Growth | -1.7% | -6% | -1% | – |
| Gross Profit | $3 | $5 | $5 | $5 |
| % Margin | 17.4% | 26.4% | 25.9% | 26.4% |
| EBITDA | $1 | $1 | $2 | $2 |
| % Margin | 8.8% | 7.3% | 8.8% | 8.9% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 5.3% | 4.2% | 5.2% | 6.9% |
| EPS Diluted | 1.22 | 1.03 | 1.28 | 1.78 |
| % Growth | 18.4% | -19.5% | -28.1% | – |
| Operating Cash Flow | $4 | $2 | $4 | $5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $4 | $2 | $4 | $5 |